About Alercell

 Dr. Frederic Scheer is a highly accomplished executive with a remarkable history of success in both private and public enterprises. With a rich reservoir of executive expertise, Mr. Scheer plays a pivotal role in shaping the corporate development and strategic direction of Alercell. His impressive track record includes guiding numerous startups to listings on major stock exchanges such as Nasdaq.

As the visionary founder of several pioneering ventures, including Interpart, the Biodegradable Products Institute, Cereplast, Biocorp, and Alercell, Dr. Scheer has made significant contributions to the fields of sustainability, biotechnology, and molecular diagnostics. His innovative work is exemplified by 15 US patents in Biotechnology, three of which pertain to cutting-edge nanoparticle technology.

Currently serving as the Founder and CEO of Alercell, Inc., Dr. Scheer leads this molecular diagnostic company with a strong focus on oncology diagnostics and prevention, furthering advancements in the medical field including AI.

Outside of the corporate world, Dr. Scheer's commitment to making a positive impact is evident in his leadership of The Scheer Foundation, a non-profit 501(c)3 organization dedicated to combating malnutrition in Africa.

Education:

• Dr. Scheer holds a pair of doctoral degrees from the University of Paris.
• An MBA from the Institut d'Études Politiques de Paris (France).
• He has also completed a pioneering course on Artificial Intelligence in Healthcare at MIT.
• Additionally, he holds a certificate of achievement from Harvard Medical School in Cancer Genomics and Precision Oncology, showcasing his dedication to advancing personalized medicine and cancer research.

His multifaceted career and philanthropic efforts showcase a remarkable blend of entrepreneurial acumen and social responsibility. 

Chief Technology Officer - Nanotechnology- Theranostics - Dr. Gleb Sukhorukov has over 25 years of experience in the field of biopolymers, after obtaining his PhD from University of Moscow, he joined Queen’s Mary University where he now holds the Chair of Biopolymers in technology. He has led several recognizable projects in the field of medicine and biopolymers and is specialized in nanoparticles. He holds over 18 patents in various sectors.

Michael Okada, CPA, is a Senior financial executive and “Big 4” CPA with over 30 years of successful experience in growth-oriented entrepreneurial companies with revenues from $10 million up to $1+ billion. Mr. Okada has over 30 years of experience in corporate finance for private and public companies. He served as CFO of Alercell since 2020. Mr. Okada earned a Bachelor of Science degree in Accounting from Santa Clara University.

Chief Medical Officer - Dr. Alexandre Scheer, MD co-founders of Alercell and currently serves as Alercell CMO. Dr. Scheer specialized in the evaluation and management of persistent pain related to orthopedic injuries. He also specialized in PRP (Platelets Rich Plasma) injections as well as Stem Cells injections. Dr. Scheer is a surgeon and did two years of neurosurgery at Albert Einstein College of Medicine Beth Israel Medical Center Department of Surgery in New York. Dr. Scheer graduated from UCLA. Dr. Scheer is the son of Frederic Scheer.

Senior Executive Vice President Hematology -Dr. Elina Tsyvkin received her MD from University of Moscow (Russia), followed by residency at Tuff University and Umass University. Dr Tsyvkin is working at Sloan Kettering Memorial where she has been holding a position in hematology malignancies/Leukemia. Dr Tsyvkin has over 25 years of experience in Hematology malignancy. Dr. Tsyvkin is associate Professor at Cornell University Medical School.

 Executive Vice President Core Laboratory Diagnostics - Dr. Donna Mendes obtained her MD from Colombia University College of Physicians & Surgeons in New York City. She is an associate Professor of Surgery at Mount Sinai School of Medicine. Internationally recognized for starting hemodialysis centers in Bermuda thus preventing residents from traveling to the United States for access procedures. Dr Mendes is Nationally recognized as the first African American female vascular surgeon to be certified by the American Board of Surgery in Vascular Surgery; Dr. Mendes was inducted into the Library of Congress.

 Executive Vice President Molecular Diagnostics - Dr. Christopher Johnson, MD. graduated from Harvard Medical School, Dr. Johnson also obtained an MCs in Biochemistry at Oxford University (UK). Since 2001 Dr. Johnson has had his own surgery practice in California / New York and Bermuda. Dr. Johnson published several research papers on Cellular studies of the etiology of abdominal aortic aneurysms and on Nuclear magnetic resonance studies of oligosaccharides isolated from fetal meconium and bovine colostrum.

 Executive Vice President Sales & Marketing North America - Mr. Darin DeLong received his BS from Mansfield University (PA) Mr. Delong Graduated from Mansfield University (PA) and has worked for over 25 years in the medical field in Fortune 500 companies in various capacity in sales & marketing. Mr. DeLong has been associated with Alercell since its inception and oversees medical supply distribution.